DGAT1 and melanoma: To test whether lipid droplet loss disrupts glycolytic and mitochondrial oxidative function in melanoma cells, we inhibited DGAT1 in human melanoma cell lines in nutrient-limited media and performed the Seahorse ATP Rate Assay (Supplementary Fig. 10a–d).